Corvus Pharmaceuticals Inc Cash Flow Quality Index

Latest as of March 2025: -0.54x

Corvus Pharmaceuticals Inc cash flow quality index. Corvus Pharmaceuticals Inc (CRVS) has a Cash Flow Quality Index of -0.54x as of March 2025. Operating cash flow of $-8.26 Million is below net income of $15.19 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Corvus Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.54x
Operating CF / Net Income

Operating Cash Flow

$-8.26 Million
USD

Net Income

$15.19 Million
USD

Data as of

Mar 2025
Most recent filing

Corvus Pharmaceuticals Inc Cash Flow Quality Index by Year (None–None)

Corvus Pharmaceuticals Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Corvus Pharmaceuticals Inc. For the full cash flow conversion analysis, see Corvus Pharmaceuticals Inc operating cash flow efficiency.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.